The NHS could improve patient outcomes substantially without simply relying on higher spending, according to a new Health Foundation report examining productivity across England’s health service. The study says structural problems, ageing infrastructure and administrative burdens are limiting what doctors, nurses and hospitals can achieve with existing resources. NHS red tape adds pressure on staff The Health Foundation’s NHS Productivity Commission says unnecessary regulation, reporting and compliance requirements are consuming staff time that could be used more effectively. It argues that fragmented accountability and short-term planning make it difficult for NHS organisations to sustain improvements. The report recommends creating a dedicated mechanism to reduce unnecessary bureaucracy while giving local NHS leaders greater freedom to improve services. It also stresses that managers and administrative staff play an important role in preventing additional non-clinical work from falling onto doctors and nurses. NHS AI use could improve productivity Technology is another major area where the report sees room for improvement. It says poor IT systems and uneven adoption of new tools continue to waste clinical time, even though artificial intelligence could help streamline administration, diagnostics and patient care. The commission recommends a national “test-and-learn” approach so the NHS can evaluate promising technologies, including AI, before expanding successful models across the system. Separate UK government work on healthcare AI has also highlighted its potential to help identify serious conditions earlier and reduce administrative workload, while stressing the need for safety and human oversight. Early diagnosis could prevent thousands of deaths Delayed diagnosis remains another productivity and health challenge. The report points to diseases including cancer, diabetes and other treatable conditions where earlier detection could improve survival and reduce the need for more complex treatment later. Its international analysis estimates that if England matched the outcomes of better-performing comparable health systems, there could be around 18,500 to 20,600 fewer treatable deaths each year. People could also gain an average of 2.5 to 4.5 additional years of good health. These figures are estimates based on comparisons between health systems rather than guaranteed outcomes from individual reforms. NHS bed gaps and ageing hospitals limit care Infrastructure remains a major obstacle. Ageing hospitals, maintenance needs and limited diagnostic, operating-theatre and bed capacity can slow patient movement through the health system. The Health Foundation has previously noted that England has fewer hospital beds and less diagnostic capacity than several comparable countries. More staff alone cannot solve those constraints if hospitals lack modern buildings, equipment, technology and enough capacity to diagnose and treat patients efficiently. NHS savings could reach £33 billion a year The commission estimates that sustained productivity improvements could eventually be worth around £33 billion annually, roughly equivalent to about $44 billion depending on exchange rates. The central argument is not that the NHS can simply cut spending, but that it can generate better outcomes from the resources already available. The Department of Health and Social Care said the NHS is already improving productivity through greater use of technology, reduced agency staffing and leaner back-office operations. It pointed to record numbers of appointments, tests and scans, while acknowledging that considerably more work remains under the government’s 10-Year Health Plan. 

Food safety officials have warned consumers against artificially coloured papads, appalams and fryums, particularly products aimed at children. Colourful Papads Warning Raises Food Safety Concerns Colourful papads, appalams and fryums may appear attractive on store shelves, but the Tamil Nadu Food Safety Department has advised consumers to avoid products containing artificial colouring agents. In a public awareness message, the department

ICMR has licensed SHetA2 to Emcure for further development as a potential treatment for HPV-related cervical precancer, though it is not yet approved for patients.   What Is SHetA2? SHetA2 is an investigational anti-HPV drug candidate being developed as a possible treatment for cervical intraepithelial neoplasia, commonly known as CIN. CIN refers to abnormal changes in the cells covering the cervix. These changes are not cancer, but high-

A breast cancer patient died before the Kerala High Court could decide her petition seeking a reduction in the price of a life-saving medicine, even though the case had been listed 57 times. The Supreme Court has now taken suo motu cognisance of the delay and issued notice to the Centre. Cancer Drug Plea Remained Pending for Nearly Four Years The petition was filed in the Kerala High Court in June 2022 by a woman undergoing treatment for b

The AAPI Tampa convention brought more than 1,000 physicians of Indian origin to Tampa, Florida, for a four-day gathering focused on global health, medical innovation and public service. The AAPI Tampa convention ran from Thursday, July 2, 2026, through Sunday, July 5, 2026, over the July 4 weekend. AAPI Tampa convention focuses on global healthcare The 2026 annual convention of the American Association of Physicians of Indian Origin included s

A viral Revlimid price comparison between the United States and India has renewed discussion about cancer drug costs, generic medicines and patient access. In an Instagram video posted by the account Spicy Gori, an American woman claimed that one Revlimid pill costs about $900 in the United States. She said she found options in India ranging from approximately Rs 35 to Rs 300 per pill, which she estimated at about 30 cents to $3. In an

World No Tobacco Day, observed annually on May 31, raises awareness about the dangers of tobacco and nicotine use. Launched by the World Health Organization in 1987, it aims to educate the public about the health, social, and environmental impacts of tobacco. Globally, over 8 million people die each year from tobacco-related illnesses, making prevention and quitting crucial. Health Risks of Tobacco Use

Roundup Lawyers Challenge $7.25 Billion Settlement Lawyers representing plaintiffs in a Supreme Court case concerning Roundup are attempting to derail a pending $7.25 billion class-action settlement. The settlement, which would resolve thousands of lawsuits against Bayer, the company that acquired Monsanto in 2018, is being criticized by some attorneys as overly favorable to the company while inadequately compensating people

Dr. Marty Makary Resigns as FDA Commissioner Dr. Marty Makary has resigned from his position as the commissioner of the U.S. Food and Drug Administration (FDA), as confirmed by President Donald Trump on May 12. In a social media post, Trump revealed that Makary had informed him of his decision to step down, effective Tuesday. While Makary did not offer an explicit reason for his resignation, Trump praised his leadership, calling him a “hard worke

​REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar

The ISDE India Edition 2026, a two-day international conference on esophageal cancer, was inaugurated on April 10, 2026, by Shri Nandamuri Balakrishna, Chairman & Managing Trustee of NBTRMCF, at The Westin Hyderabad, Madhapur. This is the first time the conference is being held in India, emphasizing the country’s growing role in esophageal cancer research and clinical expertise. The conference, in association with the Basavatarakam Indo-American Cancer Hospital & Research Institute

Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik

Cancer remains one of the most significant global health challenges, with incidence rates varying dramatically across countries. The Age-Standardised Incidence Rate (ASIR) of cancer is influenced by various factors, including lifestyle habits, healthcare infrastructure, population age, and access to screening and prevention programs. On World Cancer Day 2026, experts highlight the top 10 countries with the highest cancer rates, shedding light on the impact of these factors on global cancer pr

World Cancer Day 2026, observed on February 4, is a crucial reminder of the growing health challenge cancer poses, both in India and worldwide. The day aims to increase awareness about cancer, emphasize the importance of early detection, promote prevention, and advocate for better healthcare access for all. As cancer cases rise in India, with millions affected every year, experts highlight the life-saving benefits of detecting cancer early. With timely medical action, regular screening, and e

Scott Adams, the cartoonist whose comic strip “Dilbert” became a defining satire of modern corporate life before his career unraveled amid controversy, has died at the age of 68. His death was announced Tuesday by his former wife, Shelly Miles, during a livestream posted on Adams’ social media accounts. She said he died at his home in Northern California, where he had been receiving hospice care. Adams had revealed in 2025 that he was suffering from prostate cancer that had me

Veteran singer-songwriter Barry Manilow has revealed that he has been diagnosed with lung cancer and will undergo surgery, prompting the rescheduling of his January concert dates. The announcement was made Monday through a personal statement shared on social media, in which the 82-year-old performer described the circumstances that led to the discovery of the illness and reassured fans about his prognosis. Manilow said the diagnosis followed a period of recurring bronchitis that las

American healthcare giant Johnson & Johnson is confronting one of its most serious legal battles in the United Kingdom, as thousands of claimants have filed a collective lawsuit alleging that the company’s talc-based baby powder contained asbestos, a known carcinogen. The case, now moving through UK courts, accuses the multinational of knowingly selling contaminated products for decades while misleading consumers about their safety. According to court filings, the lawsuit invo

Grammy-winning R&B and neo-soul icon D’Angelo, celebrated for his velvet-smooth voice and profound impact on modern soul music, has died at the age of 51. His family confirmed in a statement Tuesday that the singer, born Michael Eugene Archer, passed away following a private battle with cancer. “It is with deep sorrow that we announce the passing of our beloved D’Angelo,” the family said. “He was a shining star of our family and has dimmed his light for us in this life

Former US president Joe Biden has embarked upon a new stage in his medical care after a diagnosis of aggressive prostate cancer earlier this year, his spokesperson confirmed on Saturday. The spokesman said that, in conjunction with an existing hormone regimen, Biden is now receiving a course of radiation therapy as part of a broader treatment plan for his prostate cancer. According to the spokesperson, the radiation phase is scheduled to continue for five weeks, marking a significan

Russia has taken a major step in the global fight against cancer with the announcement of Enteromix, a new mRNA-based cancer vaccine that has shown 100% efficacy and safety in early human trials. Developed by the National Medical Research Radiological Centre and the Engelhardt Institute of Molecular Biology, Enteromix was tested on 48 patients with colorectal cancer. The results revealed tumour shrinkage and zero serious side effects, positioning this innovatio